Skip to main content
. 2016 Mar 26;7(19):27243–27254. doi: 10.18632/oncotarget.8402

Figure 5. Quantitative microPET/CT ROI analysis of tumor uptake.

Figure 5

(A) Decreased tumor uptake of 18F-FDG was observed on days 7. (B) Decreased tumor uptake of 18F-AIF-NOTA-PRGD2 was observed on days 2. (*p < 0.05; **p < 0.01).